纳米CT造影剂在肺部疾病诊疗中的研究进展

  • 打印
  • 收藏
收藏成功


打开文本图片集

中图分类号:TB383文献标志码:A

Abstract: As chronic obstructive pulmonary disease and lung cancer, among other lung diseases, increasingly threatened global health,the development of efective diagnostic and treatment methods became paramount. Nanoparticle-based computed tomography (CT) contrast agents, especially those based on gold nanoparticles, became the focus of research due to their outstanding X-ray absorption capacity and biocompatibility. This paper briefly introduced CT imaging technology and elaborated on the application progress of nanoparticle-based CT contrast agents in the diagnosis and treatment of lung diseases, with a particular emphasis on gold nanoparticles and their modified derivatives.The current challenges and future directions of the technology were discussed. The study emphasized the enormous potential of nanoparticle-based CT contrast agents in the precise diagnosis and treatment of lung diseases.

Keywords: nano CT contrast agent; lung disease; diagnosis and treatment

引言

肺部疾病,如慢性阻塞性肺疾病和肺癌,已经成为全球健康领域的一大挑战,严重损害了患者的生活品质,并对社会的医疗系统造成了沉重的负担。(剩余15132字)

试读结束

monitor
客服机器人